In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, Eris Lifesciences has informed about the schedule of Analyst / Institutional Investor Meetings to be held on Friday, 22nd November, 2019.
The above information is a part of company’s filings submitted to BSE.